Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation (Q44398534)

2 December 2017

Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantation (English)

1 reference

2 December 2017

7

Ljungman P

1 reference

2 December 2017

Bjorklund A

1

1 reference

2 December 2017

Aschan J

2

1 reference

2 December 2017

Labopin M

3

1 reference

2 December 2017

Remberger M

4

1 reference

2 December 2017

Ringden O

5

1 reference

2 December 2017

Winiarski J

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

24 September 2007

1 reference

Bone Marrow Transplantation

2 December 2017

1 reference

2 December 2017

40

1 reference

2 December 2017

11

1 reference

2 December 2017

1055-1062

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705856

2 December 2017

0 references

cites work

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Infections following hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

A Proportional Hazards Model for the Subdistribution of a Competing Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Infections in adults undergoing unrelated donor bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Nonmalignant late effects after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Cytomegalovirus: from evasion to suppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

The impact of CMV on the respiratory burst of macrophages in response to Pneumocystis carinii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Thalidomide for the treatment of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Detection of CMV-matrix pp65 antigen in leucocytes by immunofluorescence as a marker of CMV disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

CMV PCR monitoring in leucocytes of transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Functional asplenia after bone marrow transplantation. A late complication related to extensive chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Corticosteroids and Lymphoid Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

High incidence of active cytomegalovirus infection among septic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: relationship to total body irradiation and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Functional hyposplenia after allogeneic bone marrow transplantation is detected by epinephrine stimulation test and splenic ultrasonography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Cytomegalovirus infection associated with and preceding chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705856

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705856

1 reference

Dimensions Publication ID

2 December 2017

0 references

1 reference